WeVote
Log In

Bill

Bill

HB 3359

Medicaid coverage; biomarker testing coverage; discretionary; effective date.

2026 Regular Session Introduced by Danny Williams

Oklahoma bill makes Medicaid biomarker testing discretionary, potentially reducing access for low-income patients while controlling state costs.

Second Reading referred to Rules
0
WeVote Research Nonpartisan
Bill Summary · HB 3359

Legislative bill overview

HB 3359 proposes to make Medicaid coverage of biomarker testing discretionary rather than mandatory in Oklahoma. Biomarker testing identifies genetic, protein, or other biological markers that can guide treatment decisions, particularly for cancer and other serious diseases. The bill would allow the state's Medicaid program to choose whether to cover these tests rather than requiring coverage.

Why is this important

Biomarker testing directly affects treatment decisions and patient outcomes—results often determine which medications or therapies are most effective for individual patients. Making coverage discretionary could reduce state Medicaid costs but may limit access to testing for low-income Oklahomans, potentially delaying diagnosis or leading to less personalized treatment. This impacts both healthcare quality and state budget priorities.

Potential points of contention

  • Medical necessity vs. cost control: Patient advocates and oncologists argue biomarker testing is essential for precision medicine, while fiscal conservatives may support discretionary coverage to control Medicaid spending
  • Access equity: Discretionary coverage could create disparities where only insured or wealthy patients reliably access testing, leaving Medicaid patients with delayed or less targeted care
  • Insurance coverage variation: Other states' Medicaid programs and private insurers increasingly mandate biomarker coverage; Oklahoma discretion could isolate the state from national medical standards and negotiating leverage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.